Manufactured stem cells to advance clinical research
Researchers supported by the NIH developed a clinical-grade stem cell line, which has the potential to accelerate the advance of new medical applications and cell-based therapies for people suffering from Alzheimer’s disease, Parkinson’s, spinal cord injury, diabetes, and muscular dystrophy. June 24, 2016